Eli Lilly Expands Vaccine Push With Deals Worth Up To $3.8B
By Al Barbarino · May 26, 2026, 3:29 PM EDT
Eli Lilly and Co. said Tuesday it will buy three companies involved in vaccine development — Curevo Inc., LimmaTech Biologics AG, and Vaccine Company Inc. — for a total of up to...
To view the full article, register now.